Three Decades of β-Lactamase Inhibitors

By Sarah M. Drawz, Robert A. Bonomo. Clinical Microbiology Reviews, 2010

1,340 citations recorded by the source corpus.

Subfields: Applied Microbiology and Biotechnology, Molecular Medicine, Pharmacology

View Paper: https://www.semanticscholar.org/paper/6b9708fd432b9e5415cc1c2a73408a27a1adc382

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Medicine

1. H. Aarts
2. A. Roberts
3. B. Guerra
4. A. V. van Hoek
5. P. Mullany
6. D. Mevius

In Pharmacology

1. Zeinab Breijyeh
2. Rafik Karaman

Citations in the corpus

• Resistance of Gram-Negative Bacteria to Current Antibacterial Agents and Approaches to Resolve It (2020, background): “The latter is only used in some European countries, Japan, and India [42].”
• Acquired Antibiotic Resistance Genes: An Overview (2011, background): “…at their active site, whereas Ambler class B β-lactamases are all metallo-enzymes who require zinc as a metal cofactor for their catalytic activities (Ambler, 1980; Bradford, 2001; Paterson and Bonomo, 2005; Wright, 2005; Poirel et al., 2007, 2010; Bush and Jacoby, 2010; Drawz and Bonomo, 2010).”